1
|
Omotayo A, Venkataraman S, McCurdy B. Constrained optimization towards marker-based tumor tracking in VMAT. Biomed Phys Eng Express 2021; 7. [DOI: 10.1088/2057-1976/abce0c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2020] [Accepted: 11/25/2020] [Indexed: 11/12/2022]
Abstract
Abstract
This study proposes that incorporating marker-based visibility constraints into the optimization of volumetric modulated arc therapy (VMAT) will generate treatment plans which not only ensure a higher chance of successfully applying real-time tumor tracking techniques, but also simultaneously satisfy dosimetric objectives. This was applied clinically and investigated for multiple disease sites (10 prostate, 5 liver, and 5 lung) using a radiotherapy optimization software (MonArc), where these new constraints were added to conventional dosimetric constraints. For all the investigated sites, three fiducial markers were located inside or around the planning target volume (PTV), and VMAT plans were created for each patient. We modified MonArc to analyze the multi-leaf collimator (MLC) beam’s-eye-view at all control points in the gantry arc, while including marker-based visibility constraints of type ‘hard’ (i.e. requiring 100% visibility of all markers, HC) and ‘soft’ (i.e. penalizes visibility for one marker [SCI] or two markers [SCII] only) in the optimization process. Dose distributions resulting from the constrained plans (HC, SCI, and SCII) were compared to the non-constrained plan (NC—plans optimized without visibility constraints) using several quantitative dose metrics including the conformity index, homogeneity index, doses to PTV and to organs-at-risk (OAR). Generally, the NC plan produced the best PTV dose conformity and the least OAR doses for the entire patient datasets, followed by the SC and then HC plans, with all the optimization approaches typically achieving acceptable dose metrics. Across the three disease sites, visibility of all three markers in MLC apertures increased from 32% to 100% of available control points as visibility constraints strengthened. Although dose metrics showed some deterioration for constrained plans (−6% for SCI up to −15% for HC using the PTV average index), the required dosimetric objectives were still satisfied in at least 90% of patients. In conclusion, we demonstrated that marker and tumour visibility constraints can be incorporated with dosimetric objectives to produce treatment plans satisfying both objectives, which should ensure greater success when applying real-time tracking for VMAT delivery.
Collapse
|
2
|
Omotayo AA, Venkataraman S, Venugopal N, McCurdy B. Feasibility study for marker-based VMAT plan optimization toward tumor tracking. J Appl Clin Med Phys 2020; 21:84-99. [PMID: 32525615 PMCID: PMC7386299 DOI: 10.1002/acm2.12892] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2019] [Revised: 03/23/2020] [Accepted: 04/07/2020] [Indexed: 12/25/2022] Open
Abstract
This work investigates the incorporation of fiducial marker‐based visibility parameters into the optimization of volumetric modulated arc therapy (VMAT) plans. We propose that via this incorporation, one may produce treatment plans that aid real‐time tumor tracking approaches employing exit imaging of the therapeutic beam (e.g., via EPID), in addition to satisfying purely dosimetric requirements. We investigated the feasibility of this approach for a thorax and prostate site using optimization software (MonArc). For a thorax phantom and a lung patient, three fiducial markers were inserted around the tumor and VMAT plans were created with two partial arcs and prescription dose of 48 Gy (4 fractions). For a prostate patient with three markers in the prostate organ, a VMAT plan was created with two partial arcs and prescription dose 72.8 Gy (28 fractions). We modified MonArc to include marker‐based visibility constraints (“hard”and “soft”). A hard constraint (HC) imposes full visibility for all markers, while a soft constraint (SC) penalizes visibility for specific markers in the beams‐eye‐view. Dose distributions from constrained plans (HC and SC) were compared to the reference nonconstrained (NC) plan using metrics including conformity index (CI), homogeneity index (HI), gradient measure (GM), and dose to 95% of planning target volume (PTV) and organs at risk (OARs). The NC plan produced the best target conformity and the least doses to the OARs for the entire dataset, followed by the SC and HC plans. Using SC plans provided acceptable dosimetric tolerances for both the target and OARs. However, OAR doses may be increased or decreased based on the constrained marker location and number of trackable markers. In conclusion, we demonstrate that visibility constraints can be incorporated into the optimization together with dosimetric objectives to produce treatment plans satisfying both objectives. This approach should ensure greater clinical success when applying real‐time tracking algorithms, using VMAT delivery.
Collapse
Affiliation(s)
- Azeez A Omotayo
- Division of Medical Physics, CancerCare Manitoba, Winnipeg, MB, Canada.,Department of Physics and Astronomy, University of Manitoba, Winnipeg, MB, Canada
| | - Sankar Venkataraman
- Division of Medical Physics, CancerCare Manitoba, Winnipeg, MB, Canada.,Department of Physics and Astronomy, University of Manitoba, Winnipeg, MB, Canada.,Department of Radiology, University of Manitoba, Winnipeg, MB, Canada
| | | | - Boyd McCurdy
- Division of Medical Physics, CancerCare Manitoba, Winnipeg, MB, Canada.,Department of Physics and Astronomy, University of Manitoba, Winnipeg, MB, Canada.,Department of Radiology, University of Manitoba, Winnipeg, MB, Canada
| |
Collapse
|
3
|
Unkelbach J, Alber M, Bangert M, Bokrantz R, Chan TCY, Deasy JO, Fredriksson A, Gorissen BL, van Herk M, Liu W, Mahmoudzadeh H, Nohadani O, Siebers JV, Witte M, Xu H. Robust radiotherapy planning. ACTA ACUST UNITED AC 2018; 63:22TR02. [DOI: 10.1088/1361-6560/aae659] [Citation(s) in RCA: 98] [Impact Index Per Article: 16.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
4
|
Trnková P, Knäusl B, Actis O, Bert C, Biegun AK, Boehlen TT, Furtado H, McClelland J, Mori S, Rinaldi I, Rucinski A, Knopf AC. Clinical implementations of 4D pencil beam scanned particle therapy: Report on the 4D treatment planning workshop 2016 and 2017. Phys Med 2018; 54:121-130. [PMID: 30337001 DOI: 10.1016/j.ejmp.2018.10.002] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/11/2018] [Revised: 09/18/2018] [Accepted: 10/02/2018] [Indexed: 12/14/2022] Open
Abstract
In 2016 and 2017, the 8th and 9th 4D treatment planning workshop took place in Groningen (the Netherlands) and Vienna (Austria), respectively. This annual workshop brings together international experts to discuss research, advances in clinical implementation as well as problems and challenges in 4D treatment planning, mainly in spot scanned proton therapy. In the last two years several aspects like treatment planning, beam delivery, Monte Carlo simulations, motion modeling and monitoring, QA phantoms as well as 4D imaging were thoroughly discussed. This report provides an overview of discussed topics, recent findings and literature review from the last two years. Its main focus is to highlight translation of 4D research into clinical practice and to discuss remaining challenges and pitfalls that still need to be addressed and to be overcome.
Collapse
Affiliation(s)
- Petra Trnková
- HollandPTC, P.O. Box 5046, 2600 GA Delft, the Netherlands; Erasmus MC, P.O. Box 5201, 3008 AE Rotterdam, the Netherlands
| | - Barbara Knäusl
- Department of Radiation Oncology, Division of Medical Radiation Physics, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna/AKH Vienna, Austria
| | - Oxana Actis
- Paul Scherrer Institute (PSI), 5232 Villigen, Switzerland
| | - Christoph Bert
- Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany
| | - Aleksandra K Biegun
- KVI-Center for Advanced Radiation Technology, University of Groningen, Groningen, the Netherlands
| | - Till T Boehlen
- Paul Scherrer Institute (PSI), 5232 Villigen, Switzerland
| | - Hugo Furtado
- Department of Radiation Oncology, Division of Medical Radiation Physics, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna/AKH Vienna, Austria
| | - Jamie McClelland
- Centre for Medical Image Computing, Dept. Medical Physics and Biomedical, University College London, London, UK
| | - Shinichiro Mori
- National Institute of Radiological Sciences for Charged Particle Therapy, Chiba, Japan
| | - Ilaria Rinaldi
- Lyon 1 University and CNRS/IN2P3, UMR 5822, 69622 Villeurbanne, France; MAASTRO Clinic, P.O. Box 3035, 6202 NA Maastricht, the Netherlands
| | | | - Antje C Knopf
- University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, the Netherlands.
| |
Collapse
|
5
|
Hamzeei M, Modiri A, Kazemzadeh N, Hagan A, Sawant A. Inverse-planned deliverable 4D-IMRT for lung SBRT. Med Phys 2018; 45:5145-5160. [PMID: 30153339 DOI: 10.1002/mp.13157] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2017] [Revised: 08/13/2018] [Accepted: 08/13/2018] [Indexed: 12/31/2022] Open
Abstract
PURPOSE We present a particle swarm optimization (PSO)-based technique to create deliverable four-dimensional (4D = 3D + time) intensity-modulated radiation therapy (IMRT) plans for lung stereotactic body radiotherapy (SBRT). The 4D planning concept uses respiratory motion as an additional degree of freedom to achieve further sparing of organs at risk (OARs). The 4D-IMRT plan involves the delivery of an order of magnitude more IMRT apertures (~15,000-20,000), with potentially large interaperture variations in the delivered fluence, compared to conventional (i.e., 3D) IMRT. In order to deliver the 4D plan in an efficient manner, we present an optimization-based aperture sequencing technique. METHOD A graphic processing unit (GPU)-enabled PSO-based inverse planning engine, developed and integrated with a research version of the Eclipse (Varian, Palo Alto, CA) treatment planning system (TPS), was employed to create 4D-IMRT plans as follows. Four-dimensional computed tomography scans (4DCTs) and beam configurations from clinical treatment plans of seven lung cancer patients were retrospectively collected, and in each case, the PSO engine iteratively adjusted aperture monitor unit (MU) weights for all beam apertures across all respiratory phases to optimize OAR dose sparing while maintaining planning target volume (PTV) coverage. We calculated the transition times from each aperture to all other apertures for each beam, taking into account the maximum leaf velocity of the multileaf collimator (MLC), and developed a mixed integer optimization technique for aperture sequencing. The goal of sequencing was to maximize delivery efficiency (i.e., minimize the time required to deliver the dose map) by accounting for leaf velocity, aperture MUs, and duration of each respiratory phase. The efficiency of the proposed delivery method was compared with that of a greedy algorithm which chose only from neighboring apertures for the subsequent steps in the sequence. RESULTS 4D-IMRT-optimized plans achieved PTV coverage comparable to clinical plans while improving OAR sparing by an average of 39.7% for D max heart, 20.5% for D max esophagus, 25.6% for D max spinal cord, and 2.1% for V 13 lung (with D max standing for maximum dose and V 13 standing for volume receiving ≥ 13 Gy). Our mixed integer optimization-based aperture sequencing enabled the delivery to be performed in fewer cycles compared to the greedy method. This reduction was 89 ± 79 cycles corresponding to an improvement of 15.94 ± 8.01%, when considering respiratory cycle duration of 4 s, and 55 ± 33 cycles corresponding to an improvement of 15.14 ± 4.45%, when considering respiratory cycle duration of 6 s. CONCLUSION PSO-based 4D-IMRT represents an attractive technique to further improve OAR sparing in lung SBRT. Efficient delivery of a large number of sparse apertures (control points) introduces a challenge in 4D-IMRT treatment planning and delivery. Through judicious optimization of the aperture sequence across all phases, such delivery can be performed on a clinically feasible time scale.
Collapse
Affiliation(s)
- Mahdi Hamzeei
- School of Medicine, University of Maryland, 685 W Baltimore St., Baltimore, MD, 21201, USA
| | - Arezoo Modiri
- School of Medicine, University of Maryland, 685 W Baltimore St., Baltimore, MD, 21201, USA
| | - Narges Kazemzadeh
- School of Medicine, University of Maryland, 685 W Baltimore St., Baltimore, MD, 21201, USA
| | - Aaron Hagan
- School of Medicine, University of Maryland, 685 W Baltimore St., Baltimore, MD, 21201, USA
| | - Amit Sawant
- School of Medicine, University of Maryland, 685 W Baltimore St., Baltimore, MD, 21201, USA
| |
Collapse
|
6
|
Al‐Ward SM, Kim A, McCann C, Ruschin M, Cheung P, Sahgal A, Keller BM. The development of a 4D treatment planning methodology to simulate the tracking of central lung tumors in an MRI-linac. J Appl Clin Med Phys 2018; 19:145-155. [PMID: 29194940 PMCID: PMC5768012 DOI: 10.1002/acm2.12233] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2017] [Revised: 10/02/2017] [Accepted: 10/30/2017] [Indexed: 12/31/2022] Open
Abstract
PURPOSE Targeting and tracking of central lung tumors may be feasible on the Elekta MRI-linac (MRL) due to the soft-tissue visualization capabilities of MRI. The purpose of this work is to develop a novel treatment planning methodology to simulate tracking of central lung tumors with the MRL and to quantify the benefits in OAR sparing compared with the ITV approach. METHODS Full 4D-CT datasets for five central lung cancer patients were selected to simulate the condition of having 4D-pseudo-CTs derived from 4D-MRI data available on the MRL with real-time tracking capabilities. We used the MRL treatment planning system to generate two plans: (a) with a set of MLC-defined apertures around the target at each phase of the breathing ("4D-MRL" method); (b) with a fixed set of fields encompassing the maximum inhale and exhale of the breathing cycle ("ITV" method). For both plans, dose accumulation was performed onto a reference phase. To further study the potential benefits of a 4D-MRL method, the results were stratified by tumor motion amplitude, OAR-to-tumor proximity, and the relative OAR motion (ROM). RESULTS With the 4D-MRL method, the reduction in mean doses was up to 3.0 Gy and 1.9 Gy for the heart and the lung. Moreover, the lung's V12.5 Gy was spared by a maximum of 300 cc. Maximum doses to serial organs were reduced by up to 6.1 Gy, 1.5 Gy, and 9.0 Gy for the esophagus, spinal cord, and the trachea, respectively. OAR dose reduction with our method depended on the tumor motion amplitude and the ROM. Some OARs with large ROMs and in close proximity to the tumor benefited from tracking despite small tumor amplitudes. CONCLUSIONS We developed a novel 4D tracking methodology for the MRL for central lung tumors and quantified the potential dosimetric benefits compared with our current ITV approach.
Collapse
Affiliation(s)
- Shahad M. Al‐Ward
- Sunnybrook Health Sciences CentreOdette Cancer CentreTorontoONCanada
| | - Anthony Kim
- Sunnybrook Health Sciences CentreOdette Cancer CentreTorontoONCanada
- Department of Radiation OncologyUniversity of TorontoTorontoONCanada
| | - Claire McCann
- Sunnybrook Health Sciences CentreOdette Cancer CentreTorontoONCanada
- Department of Radiation OncologyUniversity of TorontoTorontoONCanada
| | - Mark Ruschin
- Sunnybrook Health Sciences CentreOdette Cancer CentreTorontoONCanada
- Department of Radiation OncologyUniversity of TorontoTorontoONCanada
| | - Patrick Cheung
- Sunnybrook Health Sciences CentreOdette Cancer CentreTorontoONCanada
- Department of Radiation OncologyUniversity of TorontoTorontoONCanada
| | - Arjun Sahgal
- Sunnybrook Health Sciences CentreOdette Cancer CentreTorontoONCanada
- Department of Radiation OncologyUniversity of TorontoTorontoONCanada
| | - Brian M. Keller
- Sunnybrook Health Sciences CentreOdette Cancer CentreTorontoONCanada
- Department of Radiation OncologyUniversity of TorontoTorontoONCanada
| |
Collapse
|
7
|
Zhang Y, Yang Y, Fu W, Li X, Li T, Heron DE, Huq MS. 4D VMAT planning and verification technique for dynamic tracking using a direct aperture deformation (DAD) method. J Appl Clin Med Phys 2017; 18:50-61. [PMID: 28300367 PMCID: PMC5466079 DOI: 10.1002/acm2.12053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2016] [Revised: 12/14/2016] [Accepted: 12/16/2016] [Indexed: 11/16/2022] Open
Abstract
We developed a four‐dimensional volumetric modulated arc therapy (4D VMAT) planning technique for moving targets using a direct aperture deformation (DAD) method and investigated its feasibility for clinical use. A 3D VMAT plan was generated on a reference phase of a 4D CT dataset. The plan was composed of a set of control points including the beam angle, MLC apertures and weights. To generate the 4D VMAT plan, these control points were assigned to the closest respiratory phases using the temporal information of the gantry angle and respiratory curve. Then, a DAD algorithm was used to deform the beam apertures at each control point to the corresponding phase to compensate for the tumor motion and shape changes. Plans for a phantom and five lung cases were included in this study to evaluate the proposed technique. Dosimetric comparisons were performed between 4D and 3D VMAT plans. Plan verification was implemented by delivering the 4D VMAT plans on a moving QUASAR™ phantom driven with patient‐specific respiratory curves. The phantom study showed that the 4D VMAT plan generated with the DAD method was comparable to the ideal 3D VMAT plan. DVH comparisons indicated that the planning target volume (PTV) coverages and minimum doses were nearly invariant, and no significant difference in lung dosimetry was observed. Patient studies revealed that the GTV coverage was nearly the same; although the PTV coverage dropped from 98.8% to 94.7%, and the mean dose decreased from 64.3 to 63.8 Gy on average. For the verification measurements, the average gamma index pass rate was 98.6% and 96.5% for phantom 3D and 4D VMAT plans with 3%/3 mm criteria. For patient plans, the average gamma pass rate was 96.5% (range 94.5–98.5%) and 95.2% (range 94.1–96.1%) for 3D and 4D VMAT plans. The proposed 4D VMAT planning technique using the DAD method is feasible to incorporate the intra‐fraction organ motion and shape change into a 4D VMAT planning. It has great potential to provide high plan quality and delivery efficiency for moving targets.
Collapse
Affiliation(s)
- Yongqian Zhang
- Department of Radiation Oncology; University of Pittsburgh Cancer Institute; Pittsburgh PA 15232 USA
| | - Yong Yang
- Department of Radiation Oncology; Stanford University; Stanford CA 94305 USA
| | - Weihua Fu
- Department of Radiation Oncology; University of Pittsburgh Cancer Institute; Pittsburgh PA 15232 USA
| | - Xiang Li
- Department of Radiation Oncology; Memorial Sloan-Kettering Cancer Center; New York NY 10065 USA
| | - Tianfang Li
- Department of Radiation Oncology; Memorial Sloan-Kettering Cancer Center; New York NY 10065 USA
| | - Dwight E. Heron
- Department of Radiation Oncology; University of Pittsburgh Cancer Institute; Pittsburgh PA 15232 USA
| | - M. Saiful. Huq
- Department of Radiation Oncology; University of Pittsburgh Cancer Institute; Pittsburgh PA 15232 USA
| |
Collapse
|
8
|
Niu Y, Betzel GT, Yang X, Gui M, Parke WC, Yi B, Yu CX. Planning 4D intensity-modulated arc therapy for tumor tracking with a multileaf collimator. Phys Med Biol 2017; 62:1480-1500. [PMID: 28052050 DOI: 10.1088/1361-6560/aa56b7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
This study introduces a practical four-dimensional (4D) planning scheme of IMAT using 4D computed tomography (4D CT) for planning tumor tracking with dynamic multileaf beam collimation. We assume that patients can breathe regularly, i.e. the same way as during 4D CT with an unchanged period and amplitude, and that the start of 4D-IMAT delivery can be synchronized with a designated respiratory phase. Each control point of the IMAT-delivery process can be associated with an image set of 4D CT at a specified respiratory phase. Target is contoured at each respiratory phase without a motion-induced margin. A 3D-IMAT plan is first optimized on a reference-phase image set of 4D CT. Then, based on the projections of the planning target volume in the beam's eye view at different respiratory phases, a 4D-IMAT plan is generated by transforming the segments of the optimized 3D plan by using a direct aperture deformation method. Compensation for both translational and deformable tumor motion is accomplished, and the smooth delivery of the transformed plan is ensured by forcing connectivity between adjacent angles (control points). It is envisioned that the resultant plans can be delivered accurately using the dose rate regulated tracking method which handles breathing irregularities (Yi et al 2008 Med. Phys. 35 3955-62).This planning process is straightforward and only adds a small step to current clinical 3D planning practice. Our 4D planning scheme was tested on three cases to evaluate dosimetric benefits. The created 4D-IMAT plans showed similar dose distributions as compared with the 3D-IMAT plans on a single static phase, indicating that our method is capable of eliminating the dosimetric effects of breathing induced target motion. Compared to the 3D-IMAT plans with large treatment margins encompassing respiratory motion, our 4D-IMAT plans reduced radiation doses to surrounding normal organs and tissues.
Collapse
Affiliation(s)
- Ying Niu
- Xcision Medical Systems, LLC, Columbia, MD, United States of America
| | | | | | | | | | | | | |
Collapse
|
9
|
Modiri A, Gu X, Hagan A, Bland R, Iyengar P, Timmerman R, Sawant A. Inverse 4D conformal planning for lung SBRT using particle swarm optimization. Phys Med Biol 2016; 61:6181-202. [PMID: 27476472 DOI: 10.1088/0031-9155/61/16/6181] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
A critical aspect of highly potent regimens such as lung stereotactic body radiation therapy (SBRT) is to avoid collateral toxicity while achieving planning target volume (PTV) coverage. In this work, we describe four dimensional conformal radiotherapy using a highly parallelizable swarm intelligence-based stochastic optimization technique. Conventional lung CRT-SBRT uses a 4DCT to create an internal target volume and then, using forward-planning, generates a 3D conformal plan. In contrast, we investigate an inverse-planning strategy that uses 4DCT data to create a 4D conformal plan, which is optimized across the three spatial dimensions (3D) as well as time, as represented by the respiratory phase. The key idea is to use respiratory motion as an additional degree of freedom. We iteratively adjust fluence weights for all beam apertures across all respiratory phases considering OAR sparing, PTV coverage and delivery efficiency. To demonstrate proof-of-concept, five non-small-cell lung cancer SBRT patients were retrospectively studied. The 4D optimized plans achieved PTV coverage comparable to the corresponding clinically delivered plans while showing significantly superior OAR sparing ranging from 26% to 83% for D max heart, 10%-41% for D max esophagus, 31%-68% for D max spinal cord and 7%-32% for V 13 lung.
Collapse
Affiliation(s)
- A Modiri
- Department of Radiation Oncology, The University of Texas Southwestern Medical Center, TX, USA. Department of Radiation Oncology, The University of Maryland, School of Medicine, Baltimore, MD, USA
| | | | | | | | | | | | | |
Collapse
|
10
|
Modiri A, Gu X, Hagan AM, Sawant A. Radiotherapy Planning Using an Improved Search Strategy in Particle Swarm Optimization. IEEE Trans Biomed Eng 2016; 64:980-989. [PMID: 27362755 DOI: 10.1109/tbme.2016.2585114] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
OBJECTIVE Evolutionary stochastic global optimization algorithms are widely used in large-scale, nonconvex problems. However, enhancing the search efficiency and repeatability of these techniques often requires well-customized approaches. This study investigates one such approach. METHODS We use particle swarm optimization (PSO) algorithm to solve a 4D radiation therapy (RT) inverse planning problem, where the key idea is to use respiratory motion as an additional degree of freedom in lung cancer RT. The primary goal is to administer a lethal dose to the tumor target while sparing surrounding healthy tissue. Our optimization iteratively adjusts radiation fluence-weights for all beam apertures across all respiratory phases. We implement three PSO-based approaches: conventionally used unconstrained, hard-constrained, and our proposed virtual search. As proof of concept, five lung cancer patient cases are optimized over ten runs using each PSO approach. For comparison, a dynamically penalized likelihood (DPL) algorithm-a popular RT optimization technique is also implemented and used. RESULTS The proposed technique significantly improves the robustness to random initialization while requiring fewer iteration cycles to converge across all cases. DPL manages to find the global optimum in 2 out of 5 RT cases over significantly more iterations. CONCLUSION The proposed virtual search approach boosts the swarm search efficiency, and consequently, improves the optimization convergence rate and robustness for PSO. SIGNIFICANCE RT planning is a large-scale, nonconvex optimization problem, where finding optimal solutions in a clinically practical time is critical. Our proposed approach can potentially improve the optimization efficiency in similar time-sensitive problems.
Collapse
|
11
|
Blanck O, Wang L, Baus W, Grimm J, Lacornerie T, Nilsson J, Luchkovskyi S, Cano IP, Shou Z, Ayadi M, Treuer H, Viard R, Siebert FA, Chan MKH, Hildebrandt G, Dunst J, Imhoff D, Wurster S, Wolff R, Romanelli P, Lartigau E, Semrau R, Soltys SG, Schweikard A. Inverse treatment planning for spinal robotic radiosurgery: an international multi-institutional benchmark trial. J Appl Clin Med Phys 2016; 17:313-330. [PMID: 27167291 PMCID: PMC5690905 DOI: 10.1120/jacmp.v17i3.6151] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2015] [Revised: 01/19/2016] [Accepted: 01/18/2016] [Indexed: 11/23/2022] Open
Abstract
Stereotactic radiosurgery (SRS) is the accurate, conformal delivery of high‐dose radiation to well‐defined targets while minimizing normal structure doses via steep dose gradients. While inverse treatment planning (ITP) with computerized optimization algorithms are routine, many aspects of the planning process remain user‐dependent. We performed an international, multi‐institutional benchmark trial to study planning variability and to analyze preferable ITP practice for spinal robotic radiosurgery. 10 SRS treatment plans were generated for a complex‐shaped spinal metastasis with 21 Gy in 3 fractions and tight constraints for spinal cord (V14Gy<2 cc, V18Gy<0.1 cc) and target (coverage >95%). The resulting plans were rated on a scale from 1 to 4 (excellent‐poor) in five categories (constraint compliance, optimization goals, low‐dose regions, ITP complexity, and clinical acceptability) by a blinded review panel. Additionally, the plans were mathematically rated based on plan indices (critical structure and target doses, conformity, monitor units, normal tissue complication probability, and treatment time) and compared to the human rankings. The treatment plans and the reviewers' rankings varied substantially among the participating centers. The average mean overall rank was 2.4 (1.2‐4.0) and 8/10 plans were rated excellent in at least one category by at least one reviewer. The mathematical rankings agreed with the mean overall human rankings in 9/10 cases pointing toward the possibility for sole mathematical plan quality comparison. The final rankings revealed that a plan with a well‐balanced trade‐off among all planning objectives was preferred for treatment by most participants, reviewers, and the mathematical ranking system. Furthermore, this plan was generated with simple planning techniques. Our multi‐institutional planning study found wide variability in ITP approaches for spinal robotic radiosurgery. The participants', reviewers', and mathematical match on preferable treatment plans and ITP techniques indicate that agreement on treatment planning and plan quality can be reached for spinal robotic radiosurgery. PACS number(s): 87.55.de
Collapse
Affiliation(s)
- Oliver Blanck
- University Medical Center Schleswig-Holstein; Saphir Radiosurgery Cente.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Tachibana H, Sawant A. Four-dimensional planning for motion synchronized dose delivery in lung stereotactic body radiation therapy. Radiother Oncol 2016; 119:467-72. [PMID: 27143560 DOI: 10.1016/j.radonc.2016.03.028] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2015] [Revised: 02/17/2016] [Accepted: 03/16/2016] [Indexed: 12/20/2022]
Abstract
BACKGROUND AND PURPOSE To investigate a weighted four-dimensional (W-4D) treatment planning strategy based on the greater clinical advantage of the conformal over the intensity-modulated technique in lung stereotactic body radiotherapy (SBRT). MATERIAL AND METHODS Two planning strategies (individual-phase 4D [IP-4D] and W-4D) were evaluated in eighteen lung SBRT patients. The IP-4D plan can deliver a constant fluence during whole respiratory phases. The W-4D plan's key concept was to escalate (or reduce) fluence using a 4D optimization algorithm when the tumour target was out-of-line (or in-line) with an organ-at-risk. The fluence was converted to a dynamic multi-leaf collimator leaf sequence for deliverable 4D irradiation. RESULTS In all patients, the W-4D plan enabled planning tumour volume conformity comparable to the IP-4D plan. The W-4D plan yielded a significantly lower maximum dose than the IP-4D plan for the spinal cord (-11%; p<0.01), oesophagus (-14%; p<0.01), heart (-22%; p=0.01) and stomach (-23%; p=0.07), and a lower mean dose to liver (-19%; p=0.18) while maintaining the mean dose to lung (-1%; p=0.23). CONCLUSIONS W-4D is a robust, practical planning approach that achieves significant dose sparing relative to non-time-resolved tracking; it may be of greater clinical benefit in radiotherapy than the spatially intensity-modulated 4D approach.
Collapse
Affiliation(s)
| | - Amit Sawant
- University of Texas Southwestern Medical Center, Dallas, USA.
| |
Collapse
|
13
|
Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys 2015; 95:523-533. [PMID: 26725727 DOI: 10.1016/j.ijrobp.2015.11.002] [Citation(s) in RCA: 100] [Impact Index Per Article: 11.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2015] [Revised: 10/01/2015] [Accepted: 11/02/2015] [Indexed: 12/25/2022]
Abstract
PURPOSE The purpose of this study was to compare the impact of uncertainties and interplay on 3-dimensional (3D) and 4D robustly optimized intensity modulated proton therapy (IMPT) plans for lung cancer in an exploratory methodology study. METHODS AND MATERIALS IMPT plans were created for 11 nonrandomly selected non-small cell lung cancer (NSCLC) cases: 3D robustly optimized plans on average CTs with internal gross tumor volume density overridden to irradiate internal target volume, and 4D robustly optimized plans on 4D computed tomography (CT) to irradiate clinical target volume (CTV). Regular fractionation (66 Gy [relative biological effectiveness; RBE] in 33 fractions) was considered. In 4D optimization, the CTV of individual phases received nonuniform doses to achieve a uniform cumulative dose. The root-mean-square dose-volume histograms (RVH) measured the sensitivity of the dose to uncertainties, and the areas under the RVH curve (AUCs) were used to evaluate plan robustness. Dose evaluation software modeled time-dependent spot delivery to incorporate interplay effect with randomized starting phases of each field per fraction. Dose-volume histogram (DVH) indices comparing CTV coverage, homogeneity, and normal tissue sparing were evaluated using Wilcoxon signed rank test. RESULTS 4D robust optimization plans led to smaller AUC for CTV (14.26 vs 18.61, respectively; P=.001), better CTV coverage (Gy [RBE]) (D95% CTV: 60.6 vs 55.2, respectively; P=.001), and better CTV homogeneity (D5%-D95% CTV: 10.3 vs 17.7, respectively; P=.002) in the face of uncertainties. With interplay effect considered, 4D robust optimization produced plans with better target coverage (D95% CTV: 64.5 vs 63.8, respectively; P=.0068), comparable target homogeneity, and comparable normal tissue protection. The benefits from 4D robust optimization were most obvious for the 2 typical stage III lung cancer patients. CONCLUSIONS Our exploratory methodology study showed that, compared to 3D robust optimization, 4D robust optimization produced significantly more robust and interplay-effect-resistant plans for targets with comparable dose distributions for normal tissues. A further study with a larger and more realistic patient population is warranted to generalize the conclusions.
Collapse
|
14
|
Watkins WT, Moore JA, Gordon J, Hugo GD, Siebers JV. Multiple anatomy optimization of accumulated dose. Med Phys 2014; 41:111705. [PMID: 25370619 DOI: 10.1118/1.4896104] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE To investigate the potential advantages of multiple anatomy optimization (MAO) for lung cancer radiation therapy compared to the internal target volume (ITV) approach. METHODS MAO aims to optimize a single fluence to be delivered under free-breathing conditions such that the accumulated dose meets the plan objectives, where accumulated dose is defined as the sum of deformably mapped doses computed on each phase of a single four dimensional computed tomography (4DCT) dataset. Phantom and patient simulation studies were carried out to investigate potential advantages of MAO compared to ITV planning. Through simulated delivery of the ITV- and MAO-plans, target dose variations were also investigated. RESULTS By optimizing the accumulated dose, MAO shows the potential to ensure dose to the moving target meets plan objectives while simultaneously reducing dose to organs at risk (OARs) compared with ITV planning. While consistently superior to the ITV approach, MAO resulted in equivalent OAR dosimetry at planning objective dose levels to within 2% volume in 14/30 plans and to within 3% volume in 19/30 plans for each lung V20, esophagus V25, and heart V30. Despite large variations in per-fraction respiratory phase weights in simulated deliveries at high dose rates (e.g., treating 4/10 phases during single fraction beams) the cumulative clinical target volume (CTV) dose after 30 fractions and per-fraction dose were constant independent of planning technique. In one case considered, however, per-phase CTV dose varied from 74% to 117% of prescription implying the level of ITV-dose heterogeneity may not be appropriate with conventional, free-breathing delivery. CONCLUSIONS MAO incorporates 4DCT information in an optimized dose distribution and can achieve a superior plan in terms of accumulated dose to the moving target and OAR sparing compared to ITV-plans. An appropriate level of dose heterogeneity in MAO plans must be further investigated.
Collapse
Affiliation(s)
- W Tyler Watkins
- Department of Radiation Oncology, University of Virginia, Charlottesville, Virginia 22908 and Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia 23298
| | - Joseph A Moore
- Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland 21231 and Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia 23298
| | - James Gordon
- Henry Ford Health System, Detroit, Michigan 48202 and Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia 23298
| | - Geoffrey D Hugo
- Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia 23298
| | - Jeffrey V Siebers
- Department of Radiation Oncology, University of Virginia, Charlottesville, Virginia 22908 and Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia 23298
| |
Collapse
|
15
|
Graeff C. Motion mitigation in scanned ion beam therapy through 4D-optimization. Phys Med 2014; 30:570-7. [DOI: 10.1016/j.ejmp.2014.03.011] [Citation(s) in RCA: 65] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/20/2014] [Revised: 03/28/2014] [Accepted: 03/31/2014] [Indexed: 11/26/2022] Open
|
16
|
Graeff C, Lüchtenborg R, Eley JG, Durante M, Bert C. A 4D-optimization concept for scanned ion beam therapy. Radiother Oncol 2013; 109:419-24. [DOI: 10.1016/j.radonc.2013.09.018] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2013] [Revised: 09/20/2013] [Accepted: 09/26/2013] [Indexed: 10/26/2022]
|
17
|
Zhang P, Hunt M, Happersett L, Yang J, Zelefsky M, Mageras G. Robust plan optimization for electromagnetic transponder guided hypo-fractionated prostate treatment using volumetric modulated arc therapy. Phys Med Biol 2013; 58:7803-13. [DOI: 10.1088/0031-9155/58/21/7803] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
18
|
Na YH, Suh TS, Kapp DS, Xing L. Toward a web-based real-time radiation treatment planning system in a cloud computing environment. Phys Med Biol 2013; 58:6525-40. [DOI: 10.1088/0031-9155/58/18/6525] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
19
|
Chan MKH, Kwong DLW, Law GML, Tam E, Tong A, Lee V, Ng SCY. Dosimetric evaluation of four-dimensional dose distributions of CyberKnife and volumetric-modulated arc radiotherapy in stereotactic body lung radiotherapy. J Appl Clin Med Phys 2013; 14:4229. [PMID: 23835388 PMCID: PMC5714543 DOI: 10.1120/jacmp.v14i4.4229] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2012] [Revised: 03/09/2013] [Accepted: 02/27/2013] [Indexed: 12/02/2022] Open
Abstract
Advanced image‐guided stereotatic body lung radiotherapy techniques using volumetric‐modulated arc radiotherapy (VMAT) with four‐dimensional cone‐beam computed tomography (4D CBCT) and CyberKnife with real‐time target tracking have been clinically implemented by different authors. However, dosimetric comparisons between these techniques are lacking. In this study, 4D CT scans of 14 patients were used to create VMAT and CyberKnife treatment plans using 4D dose calculations. The GTV and the organs at risk (OARs) were defined on the end‐exhale images for CyberKnife planning and were then deformed to the midventilation images (MidV) for VMAT optimization. Direct 4D Monte Carlo dose optimizations were performed for CyberKnife (4DCK). Four‐dimensional dose calculations were also applied to VMAT plans to generate the 4D dose distributions (4DVMAT) on the exhale images for direct comparisons with the 4DCK plans. 4DCK and 4DVMAT showed comparable target conformity (1.31±0.13 vs. 1.39±0.24,p=0.05). GTV mean doses were significantly higher with 4DCK. Statistical differences of dose volume metrics were not observed in the majority of OARs studied, except for esophagus, with 4DVMAT yielding marginally higher D1% than 4DCK. The normal tissue volumes receiving 80%, 50%, and 30% of the prescription dose (V80%,V50%, and V30%) were higher with 4DVMAT, whereas 4DCK yielded slightly higher V10% in posterior lesions than 4DVMAT. VMAT resulted in much less monitor units and therefore greater delivery efficiency than CyberKnife. In general, it was possible to produce dosimetrically acceptable plans with both techniques. The selection of treatment modality should consider the dosimetric results as well as the patient's tolerance of the treatment process specific to the SBRT technique. PACS numbers: 87.53.Ly, 87.55.km
Collapse
Affiliation(s)
- Mark K H Chan
- Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
| | | | | | | | | | | | | |
Collapse
|
20
|
Chin E, Loewen SK, Nichol A, Otto K. 4D VMAT, gated VMAT, and 3D VMAT for stereotactic body radiation therapy in lung. Phys Med Biol 2013; 58:749-70. [DOI: 10.1088/0031-9155/58/4/749] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
21
|
Zhang P, Hunt M, Happersett L, Cox B, Mageras G. Incorporation of treatment plan spatial and temporal dose patterns into a prostate intrafractional motion management strategy. Med Phys 2012; 39:5429-36. [PMID: 22957610 DOI: 10.1118/1.4742846] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE Periodic MV∕KV radiographs taken during volumetric modulated arc therapy (VMAT) for hypofractionated treatment provide guidance in intrafractional motion management. The choice of imaging frequency and timing are key components in delivering the desired dose while reducing associated overhead such as imaging dose, preparation, and processing time. In this project the authors propose a paradigm with imaging timing and frequency based on the spatial and temporal dose patterns of the treatment plan. METHODS A number of control points are used in treatment planning to model VMAT delivery. For each control point, the sensitivity of individual target or organ-at-risk dose to motion can be calculated as the summation of dose degradations given the organ displacements along a number of possible motion directions. Instead of acquiring radiographs at uniform time intervals, MV∕KV image pairs are acquired indexed to motion sensitivity. Five prostate patients treated via hypofractionated VMAT are included in this study. Intrafractional prostate motion traces from the database of an electromagnetic tracking system are used to retrospectively simulate the VMAT delivery and motion management. During VMAT delivery simulation patient position is corrected based on the radiographic findings via couch movement if target deviation violates a patient-specific 3D threshold. The violation rate calculated as the percentage of traces failing the clinical dose objectives after motion correction is used to evaluate the efficacy of this approach. RESULTS Imaging indexed to a 10 s equitime interval and correcting patient position accordingly reduces the violation rate to 19.5% with intervention from 44.5% without intervention. Imaging indexed to the motion sensitivity further reduces the violation rate to 12.1% with the same number of images. To achieve the same 5% violation rate, the imaging incidence can be reduced by 40% by imaging indexed to motion sensitivity instead of time. CONCLUSIONS The simulation results suggest that image scheduling according to the characteristics of the treatment plan can improve the efficiency of intrafractional motion management. Using such a technique, the accuracy of delivered dose during image-guided hypofractionated VMAT treatment can be improved.
Collapse
Affiliation(s)
- Pengpeng Zhang
- Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
| | | | | | | | | |
Collapse
|
22
|
Wu JK, Wu CJ, Cheng JCH. Programmable segmented volumetric modulated arc therapy for respiratory coordination in pancreatic cancer. Radiother Oncol 2012; 104:386-9. [DOI: 10.1016/j.radonc.2012.02.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2011] [Revised: 02/04/2012] [Accepted: 02/07/2012] [Indexed: 11/26/2022]
|
23
|
Merrow CE, Wang IZ, Podgorsak MB. A dosimetric evaluation of VMAT for the treatment of non-small cell lung cancer. J Appl Clin Med Phys 2012; 14:4110. [PMID: 23318374 PMCID: PMC5714051 DOI: 10.1120/jacmp.v14i1.4110] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2012] [Revised: 08/14/2012] [Accepted: 08/29/2012] [Indexed: 12/14/2022] Open
Abstract
The purpose of this study was to demonstrate the dosimetric potential of volumetric-modulated arc therapy (VMAT) for the treatment of patients with medically inoperable stage I/II non-small cell lung cancer (NSCLC) with stereotactic body radiation therapy (SBRT). Fourteen patients treated with 3D CRT with varying tumor locations, tumor sizes, and dose fractionation schemes were chosen for study. The prescription doses were 48 Gy in 4 fractions, 52.5 Gy in 5 fractions, 57.5 Gy in 5 fractions, and 60 Gy in 3 fractions for 2, 5, 1, and 6 patients, respectively. VMAT treatment plans with a mix of two to three full and partial noncoplanar arcs with 5°-25° separations were retrospectively generated using Eclipse version 10.0. The 3D CRT and VMAT plans were then evaluated by comparing their target dose, critical structure dose, high dose spillage, and low dose spillage as defined according to RTOG 0813 and RTOG 0236 protocols. In the most dosimetrically improved case, VMAT was able to decrease the dose from 17.35 Gy to 1.54 Gy to the heart. The D(2cm) decreased in 11 of 14 cases when using VMAT. The three that worsened were still within the acceptance criteria. Of the 14 3D CRT plans, seven had a D(2cm) minor deviation, while only one of the 14 VMAT plans had a D(2cm) minor deviation. The R(50%) improved in 13 of the 14 VMAT cases. The one case that worsened was still within the acceptance criteria of the RTOG protocol. Of the 14 3D CRT plans, seven had an R(50%) deviation. Only one of the 14 VMAT plans had an R(50%) deviation, but it was still improved compared to the 3D CRT plan. In this cohort of patients, no evident dosimetric compromises resulted from planning SBRT treatments with VMAT relative to the 3D CRT treatment plans actually used in their treatment.
Collapse
Affiliation(s)
- Caitlin E Merrow
- Department of Radiation Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
| | | | | |
Collapse
|
24
|
Zhang P, Mah D, Happersett L, Cox B, Hunt M, Mageras G. Determination of action thresholds for electromagnetic tracking system-guided hypofractionated prostate radiotherapy using volumetric modulated arc therapy. Med Phys 2011; 38:4001-8. [PMID: 21858997 DOI: 10.1118/1.3596776] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
PURPOSE Hypofractionated prostate radiotherapy may benefit from both volumetric modulated are therapy (VMAT) due to shortened treatment time and intrafraction real-time monitoring provided by implanted radiofrequency(RF) transponders. The authors investigate dosimetrically driven action thresholds (whether treatment needs to be interrupted and patient repositioned) in VMAT treatment with electromagnetic (EM) tracking. METHODS VMAT plans for five patients are generated for prescription doses of 32.5 and 42.5 Gy in five fractions. Planning target volume (PTV) encloses the clinical target volume (CTV) with a 3 mm margin at the prostate-rectal interface and 5 mm elsewhere. The VMAT delivery is modeled using 180 equi-spaced static beams. Intrafraction prostate motion is simulated in the plan by displacing the beam isocenter at each beam assuming rigid organ motion according to a previously recorded trajectory of the transponder centroid. The cumulative dose delivered in each fraction is summed over all beams. Two sets of 57 prostate motion trajectories were randomly selected to form a learning and a testing dataset. Dosimetric end points including CTV D95%, rectum wall D1cc, bladder wall D1cc, and urethra Dmax, are analyzed against motion characteristics including the maximum amplitude of the anterior-posterior (AP), superior-inferior (SI), and left-right components. Action thresholds are triggered when intrafraction motion causes any violations of dose constraints to target and organs at risk (OAR), so that treatment is interrupted and patient is repositioned. RESULTS Intrafraction motion has a little effect on CTV D95%, indicating PTV margins are adequate. Tight posterior and inferior action thresholds around 1 mm need to be set in a patient specific manner to spare organs at risk, especially when the prescription dose is 42.5 Gy. Advantages of setting patient specific action thresholds are to reduce false positive alarms by 25% when prescription dose is low, and increase the sensitivity of detecting dose limits violations by 30% when prescription dose is high, compared to a generic 2 mm action box. The sensitivity and specificity calculated from the testing dataset are consistent to the learning set, which indicates that the patient specific approach is reliable and reproducible within the scope of the prostate database. CONCLUSIONS This work introduces a formalism for ensuring a VMAT delivery meets the most clinically important dose requirements by using patient specific and dosimetric-driven action thresholds to hold the beam and reposition the patient when necessary. Such methods can provide improved sensitivity and specificity compared to conventional methods, which assume directionally symmetric action thresholds.
Collapse
Affiliation(s)
- Pengpeng Zhang
- Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
| | | | | | | | | | | |
Collapse
|
25
|
Xie Y, Chao M, Xiong G. Deformable Image Registration of Liver With Consideration of Lung Sliding Motion. Med Phys 2011; 38:5351-61. [DOI: 10.1118/1.3633902] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
26
|
Chin E, Otto K. Investigation of a novel algorithm for true 4D-VMAT planning with comparison to tracked, gated and static delivery. Med Phys 2011; 38:2698-707. [DOI: 10.1118/1.3578608] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|